Greenpharma invests in the enzymatic synthesis domain

Greenpharma and ICOA of the University of Orleans joins their expertise to create an innovative platform of white biotechnology for cosmetics within the company. This platform aims at the development of new methods of enzymatic bioprocess at the pilote scale by producing new compounds. A product catalogue is being set up and the platform is available through R&D services.